SEC EDGAR · Company announcement
LH: Company disclosure
Filed 8-K for an event or period dated 2026-09-10. Company disclosure.
Follow LH- Became public
- Sep 10, 2026, 4:47 PM EDT
- Event / period date
- Sep 10, 2026
- Collected
- Nov 9, 2026, 3:46 AM EST
Why this is connected
This filing identifies LABCORP HOLDINGS INC. as the issuer of the security. The company's SEC identifier connects it to LH.
Press Release dated ↗Source evidence
Read the source excerpt or record
Item 7.01. Regulation FD Disclosure. Labcorp Holdings Inc. (the “Company”) (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today hosted its 2026 Investor Day (“Investor Day”), where the company provided an in-depth review of its growth strategy, innovation roadmap, and long-term financial outlook. In connection with Investor Day, the Company issued a press release that, among other things, discussed its business strategy, reaffirmed its full-year 2026 guidance, and provided its long-term financial outlook through 2029. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. The Investor Day presentation used by members of the Company’s executive leadership team, which includes information regarding the matters discussed by the Company at its Investor Day and in the press release, has been posted on the Labcorp Investor Relations website at ir.labcorp.com. In addition, a copy of this presentation is furnished as Exhibit 99.2 hereto and incorporated by reference herein. The information in this Current Report on Form 8-K (including the exhibits attached hereto) shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K (including the exhibits attached hereto) shall not be deemed incorporated by reference into any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing or document. Item 9.01. Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated September 10 , 2026 issued by
Price change after we could observe it
+0.36% LH
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in LH
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
- Sep 9, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Labcorp Holdings LH
$1K–$15K · Traded Aug 7, 2026 · disclosed Sep 9, 2026 · Dependent
- Sep 9, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Labcorp Holdings LH
$1K–$15K · Traded Aug 6, 2026 · disclosed Sep 9, 2026 · Dependent
- Sep 9, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
Sold (partial) Labcorp Holdings LH
$1K–$15K · Traded Aug 5, 2026 · disclosed Sep 9, 2026 · Dependent
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Mar 10, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Feb 11, 2026 · disclosed Mar 10, 2026 · Dependent
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.